Foreign Service GLP-1 coverage in 2027: 50% with no deductible, and monthly weigh-ins to stay covered

From January 1, 2027, the Foreign Service Benefit Plan raises the cost share for GLP-1s prescribed for an anti-obesity use to 50%, with no deductible. To keep the drug you must log four weigh-ins and four Teladoc app sessions a month.

If 50% or the program is too much: cash now

What the Foreign Service brochure says

The cost share for GLP-1 medications prescribed for an anti-obesity indication will increase to 50% coinsurance, with no deductible, at in-network pharmacies and out-of-network pharmacies outside the 50 United States. Members will continue to pay 100% of the cost at out-of-network pharmacies within the 50 United States.

Source: Foreign Service Benefit Plan 2027 brochure, Changes section, on opm.gov, read November 2, 2026.

• Inside the 50 states, an out-of-network pharmacy still means you pay all of the cost.
• The EncircleRx program runs through Teladoc Health and is mandatory.
• The brochure asks for four documented weigh-ins and four app engagements a month to keep receiving the drug.

The brochure says some medications need a coverage review first, so confirm yours before you fill it abroad.

What cash costs today

The brochure states a share of the plan allowance. Ask the plan for your drug's allowance, then compare it with these.

Compounded semaglutide and tirzepatide are pharmacy-made versions that are not FDA-approved and are not Wegovy, Ozempic, Zepbound or Mounjaro.

All federal plans also sit under OPM's 2027 rule on GLP-1 coverage.

Frequently asked questions

Cash does not go through your plan and does not count toward its deductible. 2027 open enrollment dates.